Previous Article | Next Article 
Journal of Clinical Microbiology, March 2004, p. 1277-1279, Vol. 42, No. 3
0095-1137/04/$08.00+0 DOI: 10.1128/JCM.42.3.1277-1279.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Evaluation of Different Methods To Detect Methicillin Resistance in Small-Colony Variants of Staphylococcus aureus
Frank Kipp, Karsten Becker, Georg Peters, and Christof von Eiff*
Institute of Medical Microbiology, University Hospital of Münster, 48149 Münster, Germany
Received 28 June 2003/
Returned for modification 10 November 2003/
Accepted 19 November 2003

ABSTRACT
To evaluate different methods for their abilities to detect
methicillin resistance in small-colony variants (SCVs) of
Staphylococcus aureus, 11 different methicillin-resistant
S. aureus (MRSA)
clones with the SCV phenotype were used in this study. The slow
growth of SCVs often makes testing by disk diffusion or by automated
methods invalid. Only detection of the
mecA gene by PCR and
the MRSA-Screen latex agglutination test using a higher colony
number were shown to be reliable methods to rapidly detect methicillin
resistance in these variants.

INTRODUCTION
Considering the increasing incidence of infections due to methicillin-resistant
Staphylococcus aureus (MRSA), reliable, accurate, and rapid
testing for methicillin resistance is essential for both antibiotic
therapy and infection control regimens (
1,
12). However, staphylococci
may have mechanisms for resisting therapy that extend beyond
the classical mechanisms. The discovery and characterization
of
S. aureus small-colony variants (SCVs) have provided new
insight into the understanding of the pathogenesis associated
with staphylococcal diseases (
14,
15). These variants are increasingly
reported for antibiotic-refractory, recurrent, and/or persistent
infections (
7,
8,
13,
16,
18,
23,
24). SCVs gain a survival
advantage from their ability to hide within host cells, which
protects this naturally occurring subpopulation of
S. aureus from host defenses and decreases exposure to antibiotics (
7,
15,
22,
23,
25). The generation time for
S. aureus SCVs is six-
to ninefold longer than that for metabolically normal
S. aureus,
resulting in tiny colonies that are frequently not visible before
48 to 72 h of incubation. Consequently, correct identification
and susceptibility testing for clinical laboratories become
complicated (
15,
18,
23), which may result in diagnostic underestimation
and therapeutic failures (
13,
14,
16,
17,
23,
24). A particular
problem for therapy as well as for diagnosis is the combination
of the SCV phenotype and methicillin resistance. Within a period
of 6 years, we collected 11 different MRSA clones with the SCV
phenotype in our laboratory (approximately 0.5 to 2% of the
MRSA strains collected at our institution show the SCV phenotype).
The aims of this study were (i) to evaluate the influence of SCV phenotype on the detection of methicillin resistance and (ii) to compare different methods for their abilities to detect methicillin resistance in S. aureus SCVs by using a well-defined strain collection of methicillin-resistant SCVs and their clonal identical parent strains.
S. aureus isolates were identified and characterized as SCVs on the basis of the following: pinpoint colonies (incubation on Columbia agar, brain heart infusion plus 5% NaCl, and Schaedler agar for 48 to 72 h), decreased pigment formation, reduced hemolytic activity, and low coagulase activity. Very small colonies on Columbia agar were suspected as SCVs if they grew nearly normally on Schaedler agar (13). Identification as S. aureus was based on conventional criteria, including the coagulase tube test and the Api-Staph system (ATB32 Staph; bioMérieux, Marcy-l'Etoile, France). In addition, all strains with the SCV phenotype were confirmed as S. aureus by testing the S. aureus-specific nuc gene (2). To determine the clonal relationship of the strain pairs (SCV and normal phenotype isolated from a single patient) and to compare strains between different patients, SmaI digests of total bacterial DNA were resolved by pulsed-field gel electrophoresis as described previously (7, 24).
In total, 11 different clones of MRSA SCVs collected from 10 patients with persistent and recurrent infections were included in this study. In addition, eight isolates with the normal phenotype (clonally identical to the corresponding SCVs), which were recovered in the same (or subsequent) clinical specimens as were the SCVs, were also included in the study. From two patients, no strain with a normal phenotype was isolated. From one patient, two different clonal SCVs were isolated, and therefore both strains were included (strains 6a and 6b). Auxotrophy of SCVs for hemin, menadione, and thymidine was tested as described previously (7, 23).
The following susceptibility testing methods were evaluated for their abilities to detect methicillin resistance in SCVs in comparison with normal-phenotype strains: disk diffusion test on Mueller-Hinton agar, supplemented with 2% NaCl (30°C) with 5-µg oxacillin disks; Etest (AB Biodisk) on Mueller-Hinton agar, supplemented with 2% NaCl (30°C); microdilution method with Mueller-Hinton medium, supplemented with 2% NaCl (30°C); MRSA-Screen latex agglutination test (Denka Seiken Co. Ltd., Tokyo, Japan); and determination of MICs by Vitek 2 (bioMérieux). Determination of the presence of the mecA gene was performed as described elsewhere (11).
Apart from prolonged incubation periods (up to 72 h) and an increased number of colonies required for the MRSA-Screen latex agglutination test, the techniques were applied according to the instructions of the manufacturers and the recommendations of the Deutsches Institut für Normung (5).
The results for the detection of methicillin resistance in SCVs are summarized in Table 1. While the number of isolates tested is limited, it should be stressed that 11 different clonal lineages of methicillin-resistant strains with the SCV phenotype were included in this study. A correlation between type of auxotrophy and detection of methicillin resistance in SCVs was not observed.
In the testing of our collection of
S. aureus SCVs, the disk
diffusion test detected only two strains as methicillin resistant
following 24 h of incubation. After 48 h, another two strains
were determined to be methicillin resistant. Prolonged incubation
times up to 72 h did not reveal additional methicillin-resistant
strains. Three strains appeared to be susceptible after 48 h
of incubation, with zone diameters of

16 mm (
5).
Four strains did not show any growth following 72 h of incubation.
Testing the SCVs for oxacillin resistance by Etest showed results
similar to those of the disk diffusion test. Both the disk diffusion
test and Etest failed to detect resistance in the same strains
(Table
1). Only one further MRSA strain was detected after 24
h of incubation. Determination of MICs by Vitek 2 indicated
six MRSA SCVs. One strain was misidentified as methicillin susceptible,
with the MIC being 0.5 µg/ml, and in four strains (the
same strains which did not show any growth in the disk diffusion
test and Etest) measurement was canceled by the Vitek 2 system.
By use of the microdilution test, nine strains were found to be methicillin resistant, including all of the four strains that were misidentified as methicillin susceptible due to a lack of growth in the previously described susceptibility tests. Using an inoculum of one or two colonies according to the manufacturer's recommendations, only four MRSA SCVs were detected in the MRSA-Screen latex agglutination test. If the number of colonies used for this test was increased drastically (approximately a loopful with 100 to 200 SCV colonies, corresponding to approximately one or two colonies with normal phenotype), all SCVs were identified as methicillin resistant.
All S. aureus strains with the normal phenotype were identified as methicillin resistant by all test methods used. Only by PCR targeting mecA were all strains testedirrespective of their phenotypeconfirmed as methicillin resistant.
The SCV phenotype has a significant impact on the sensitivity of the conventional methods used for the detection of methicillin resistance in staphylococci. Tests including the disk diffusion test, Etest, and microdilution failed to detect the methicillin resistance phenotype in SCVs accurately, except for the recently introduced MRSA-Screen latex agglutination test. Most evaluations of this latex agglutination test report a sensitivity for detection of resistant strains of
97%, but none of them included S. aureus SCVs (3, 4, 6, 9, 10, 19-21). Only 4 of 11 tested strains were correctly identified as MRSA when we used the MRSA-Screen latex agglutination test to identify PBP 2a (mecA product) according to the manufacturer's instructions. With the use of a drastically increased number of colonies, the latex agglutination test showed 100% correlation with mecA PCR. In view of increasing infections due to MRSA and to S. aureus SCVs, it seems advisablefollowing recovery of S. aureus SCVs from clinical specimensto use susceptibility testing methods which are also able to detect methicillin resistance in SCVs (13, 17, 23). Furthermore, the evaluation of new susceptibility testing methods for S. aureus should include variant phenotypes and morphotypes.
In summary, results of susceptibility testing by the use of disk diffusion or automated methods are often invalid, since the colonies may be too small to be seen on agar or to be detected by optical density measurements in automated systems (15). Notably, a rejection by the Vitek 2 system should alert the clinical microbiologist to search for SCVs. Compared with conventional testing methods, only detection of the mecA gene by PCR and the MRSA-Screen latex agglutination test is able rapidly and reliably to detect methicillin resistance in S. aureus SCVs. With the use of drastically increased numbers of colonies, identification of methicillin resistance in S. aureus SCVs by applying the MRSA-Screen test is a reliable alternative for clinical laboratories where PCR or DNA hybridization methods for the mecA gene are not readily available.

ACKNOWLEDGMENTS
We sincerely thank A. Feldkamp, S. Weber, and B. Schuhen for
expert technical assistance and D. Schwindt for a careful review
of the manuscript.

FOOTNOTES
* Corresponding author. Mailing address: University of Münster, Institute of Medical Microbiology, D-48149 Münster, Germany. Phone: (49) 251 83-55360. Fax: (49) 251 83-55350. E-mail:
eiffc{at}uni-muenster.de.


REFERENCES
1 - Berger-Bächi, B. 1999. Genetic basis of methicillin resistance in Staphylococcus aureus. Cell. Mol. Life Sci. 56:764-770.[CrossRef][Medline]
2 - Brakstad, O. G., K. Aasbakk, and J. A. Maeland. 1992. Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene. J. Clin. Microbiol. 30:1654-1660.[Abstract/Free Full Text]
3 - Cavassini, M., A. Wenger, K. Jaton, D. S. Blanc, and J. Bille. 1999. Evaluation of MRSA-Screen, a simple anti-PBP 2a slide latex agglutination kit, for rapid detection of methicillin resistance in Staphylococcus aureus. J. Clin. Microbiol. 37:1591-1594.[Abstract/Free Full Text]
4 - Cuny, C., B. Pasemann, and W. Witte. 1999. Detection of oxacillin resistance in Staphylococcus aureus by screening tests. Eur. J. Clin. Microbiol. Infect. Dis. 18:834-836.[CrossRef][Medline]
5 - Deutsches Institut für Normung. 2000. Medical microbiology. Susceptibility testing of pathogens to antimicrobial agents. Approved standard, 3rd ed. Beuth, Berlin, Germany.
6 - Horstkotte, M. A., J. K. Knobloch, H. Rohde, and D. Mack. 2001. Rapid detection of methicillin resistance in coagulase-negative staphylococci by a penicillin-binding protein 2a-specific latex agglutination test. J. Clin. Microbiol. 39:3700-3702.[Abstract/Free Full Text]
7 - Kahl, B., M. Herrmann, A. S. Everding, H. G. Koch, K. Becker, E. Harms, R. A. Proctor, and G. Peters. 1998. Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J. Infect. Dis. 177:1023-1029.[Medline]
8 - Kipp, F., W. Ziebuhr, K. Becker, V. Krimmer, N. Höß, G. Peters, and C. von Eiff. 2003. Detection of Staphylococcus aureus by 16S rRNA-directed in situ hybridisation in a patient with a brain abscess caused by small colony variants. J. Neurol. Neurosurg. Psychiatry 74:1000-1002.[Abstract/Free Full Text]
9 - Louie, L., A. Majury, J. Goodfellow, M. Louie, and A. E. Simor. 2001. Evaluation of a latex agglutination test (MRSA-Screen) for detection of oxacillin resistance in coagulase-negative staphylococci. J. Clin. Microbiol. 39:4149-4151.[Abstract/Free Full Text]
10 - Louie, L., S. O. Matsumura, E. Choi, M. Louie, and A. E. Simor. 2000. Evaluation of three rapid methods for detection of methicillin resistance in Staphylococcus aureus. J. Clin. Microbiol. 38:2170-2173.[Abstract/Free Full Text]
11 - Murakami, K., W. Minamide, K. Wada, E. Nakamura, H. Teraoka, and S. Watanabe. 1991. Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction. J. Clin. Microbiol. 29:2240-2244.[Abstract/Free Full Text]
12 - Peters, G., and K. Becker. 1996. Epidemiology, control and treatment of methicillin-resistant Staphylococcus aureus. Drugs 52(Suppl. 2):50-54.
13 - Proctor, R. A., D. M. Bates, and P. J. McNamara. 2001. Electron transport-deficient Staphylococcus aureus small-colony variants as emerging pathogens, p. 95-110. In W. M. Scheld, W. A. Craig, and J. M. Hughes (ed.), Emerging infections 5. ASM Press, Washington, D.C.
14 - Proctor, R. A., B. Kahl, C. von Eiff, P. E. Vaudaux, D. P. Lew, and G. Peters. 1998. Staphylococcal small colony variants have novel mechanisms for antibiotic resistance. Clin. Infect. Dis. 27(Suppl. 1):S68-S74.
15 - Proctor, R. A., and G. Peters. 1998. Small colony variants in staphylococcal infections: diagnostic and therapeutic implications. Clin. Infect. Dis. 27:419-422.[Medline]
16 - Proctor, R. A., P. van Langevelde, M. Kristjansson, J. N. Maslow, and R. D. Arbeit. 1995. Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. Clin. Infect. Dis. 20:95-102.[Medline]
17 - Seifert, H., C. von Eiff, and G. Fätkenheuer. 1999. Fatal case due to methicillin-resistant Staphylococcus aureus small colony variants in an AIDS patient. Emerg. Infect. Dis. 5:450-453.[Medline]
18 - Seifert, H., H. Wisplinghoff, P. Schnabel, and C. von Eiff. 2003. Small colony variants (SCVs) of Staphylococcus aureus as a cause of pacemaker-related infection. Emerg. Infect. Dis. 9:1316-1318.[Medline]
19 - Smyth, R. W., G. Kahlmeter, L. B. Olsson, and B. Hoffman. 2001. Methods for identifying methicillin resistance in Staphylococcus aureus. J. Hosp. Infect. 48:103-107.[CrossRef][Medline]
20 - Swenson, J. M., P. P. Williams, G. Killgore, C. M. O'Hara, and F. C. Tenover. 2001. Performance of eight methods, including two new rapid methods, for detection of oxacillin resistance in a challenge set of Staphylococcus aureus organisms. J. Clin. Microbiol. 39:3785-3788.[Abstract/Free Full Text]
21 - van Leeuwen, W. B., C. van Pelt, A. Luijendijk, H. A. Verbrugh, and W. H. F. Goessens. 1999. Rapid detection of methicillin resistance in Staphylococcus aureus isolates by the MRSA-Screen latex agglutination test. J. Clin. Microbiol. 37:3029-3030.[Abstract/Free Full Text]
22 - Vaudaux, P., P. Francois, C. Bisognano, W. L. Kelley, D. P. Lew, J. Schrenzel, R. A. Proctor, P. J. McNamara, G. Peters, and C. von Eiff. 2002. Increased expression of clumping factor and fibronectin-binding proteins by hemB mutants of Staphylococcus aureus expressing small colony variant phenotypes. Infect. Immun. 70:5428-5437.[Abstract/Free Full Text]
23 - Von Eiff, C., K. Becker, D. Metze, G. Lubritz, J. Hockmann, T. Schwarz, and G. Peters. 2001. Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: a cause for antibiotic treatment failure in a patient with Darier's disease. Clin. Infect. Dis. 32:1643-1647.[CrossRef][Medline]
24 - Von Eiff, C., D. Bettin, R. A. Proctor, B. Rolauffs, N. Lindner, W. Winkelmann, and G. Peters. 1997. Recovery of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis. Clin. Infect. Dis. 25:1250-1251.[Medline]
25 - Von Eiff, C., C. Heilmann, R. A. Proctor, C. Woltz, G. Peters, and F. Götz. 1997. A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly. J. Bacteriol. 179:4706-4712.[Abstract/Free Full Text]
Journal of Clinical Microbiology, March 2004, p. 1277-1279, Vol. 42, No. 3
0095-1137/04/$08.00+0 DOI: 10.1128/JCM.42.3.1277-1279.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Lannergard, J., von Eiff, C., Sander, G., Cordes, T., Seggewiss, J., Peters, G., Proctor, R. A., Becker, K., Hughes, D.
(2008). Identification of the Genetic Basis for Clinical Menadione-Auxotrophic Small-Colony Variant Isolates of Staphylococcus aureus. Antimicrob. Agents Chemother.
52: 4017-4022
[Abstract]
[Full Text]
-
Abbott, Y., Leonard, N., Markey, B., Rossney, A., Dunne, J.
(2007). Persistence of MRSA infection. Vet Rec.
160: 851-852
[Full Text]
-
Vergison, A., Denis, O., Deplano, A., Casimir, G., Claeys, G., DeBaets, F., DeBoeck, K., Douat, N., Franckx, H., Gigi, J., Ieven, M., Knoop, C., Lebeque, P., Lebrun, F., Malfroot, A., Paucquay, F., Pierard, D., Van Eldere, J., Struelens, M. J.
(2007). National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients. J Antimicrob Chemother
59: 893-899
[Abstract]
[Full Text]
-
von Eiff, C., Friedrich, A. W., Becker, K., Peters, G.
(2005). Comparative In Vitro Activity of Ceftobiprole against Staphylococci Displaying Normal and Small-Colony Variant Phenotypes. Antimicrob. Agents Chemother.
49: 4372-4374
[Abstract]
[Full Text]
-
Kipp, F., Kahl, B. C., Becker, K., Baron, E. J., Proctor, R. A., Peters, G., von Eiff, C.
(2005). Evaluation of Two Chromogenic Agar Media for Recovery and Identification of Staphylococcus aureus Small-Colony Variants. J. Clin. Microbiol.
43: 1956-1959
[Abstract]
[Full Text]
-
Breitkopf, C., Hammel, D., Scheld, H. H., Peters, G., Becker, K.
(2005). Impact of a Molecular Approach to Improve the Microbiological Diagnosis of Infective Heart Valve Endocarditis. Circulation
111: 1415-1421
[Abstract]
[Full Text]